Leveraging Israel’s Ideal Hub for Medical Device Clinical Studies and Evaluation

Clinical trial medical device

In the ever-evolving world of medical device innovation, the importance of rigorous clinical studies, clinical evaluation, and device performance studies cannot be overstated.

These pivotal phases define a device’s safety, efficacy, and overall performance, significantly influencing regulatory approval and market acceptance. F

Fortunately, there’s a location that stands out as an ideal hub for these critical endeavors – Israel.

Why Israel for Clinical Studies and Evaluations?

Israel’s Vibrant Innovation Ecosystem, often referred to as the “Startup Nation,” Israel fosters a thriving innovation ecosystem that encourages entrepreneurship and research in various fields, including healthcare and medical technology.

Collaborating with this dynamic network provides medical device companies with access to groundbreaking innovations and expertise, enriching the development and evaluation of their devices.

World-Class Hospitals and Research Centers

Israel is home to a network of world-class hospitals, clinics, and medical research centers renowned for their excellence in patient care, clinical research, and medical education.

These institutions offer state-of-the-art facilities, cutting-edge medical equipment, and a pool of highly skilled healthcare professionals, making them ideal partners for clinical studies and evaluations. Importantly, all Israeli hospitals, whether governmental or private, incorporate clinical studies as part of their business model.

Medical Device Clinical Trials in Israel

Clinical trials, clinical evaluation, and medical device performance studies are pivotal phases in the development and evaluation of medical devices.

Conducting these trials in Israel presents several advantages, but understanding and complying with the local regulatory requirements set forth by the Israeli Ministry of Health (IMOH) is essential.

The IMOH, particularly its AMAR division, is known for its unwavering commitment to patient safety and stringent regulatory standards.

Collaborating with local Israeli regulatory experts can streamline the approval process, helping companies navigate the regulatory landscape efficiently and accelerating their path to market.

Requirements for Clinical Trials in Israel

In the table below you can find all you need to conduct medical device clinical trials, clinical evaluation, and medical device performance studies in Israel:

Requirement Details
Regulatory Approval

 Before initiating any clinical trial in Israel, regulatory approval from the IMOH is mandatory.

  • Companies submit a comprehensive clinical trial application that includes detailed information about the study design, objectives, patient population, investigational device(s), and safety measures.
Ethical Review
  • Clinical trials must undergo ethical review by an accredited ethics committee in Israel.

  • The ethical review assesses the ethical implications of the study, ensuring that it adheres to ethical principles, respects patient rights, and prioritizes participant safety and welfare.
Informed Consent
  • Obtaining informed consent from Israeli study participants is a fundamental requirement.

  • Participants and patients must fully understand the study’s purpose, procedures, potential risks, and benefits before providing their consent.
Qualified Investigator
  • Clinical trials must be conducted under the supervision of a qualified and experienced investigator (usually the hospital’s department manager)

  • The investigator plays a pivotal role in ensuring the trial’s integrity, patient safety, and data accuracy.
Adherence to GCP
  • Compliance with Good Clinical Practice (GCP) guidelines

  • GCP standards encompass ethical and scientific quality requirements for designing, conducting, recording, and reporting clinical trials.

  • Adhering to GCP will ensure the validity and credibility of the trial results.
Monitoring and Auditing
  • The IMOH may conduct audits and inspections of clinical trials to ensure compliance with regulatory standards.

  • Sponsors and investigators must maintain thorough records and cooperate fully with IMOH audits.
Safety Reporting
  • Any adverse events or unexpected complications that occur during the trial must be promptly reported to the IMOH.

  • Safety monitoring and reporting mechanisms are integral to safeguarding participants’ well-being.
Data Integrity
  • Maintaining the integrity and confidentiality of clinical trial data is paramount.

  • Adequate data management practices, including patient information privacy, security, and controlled access, are essential.
Record Keeping
  • Accurate record-keeping throughout the trial is essential

  • Tracking progress, documenting results, and providing transparency to regulatory authorities.
Trial Completion and Reporting
  • Comprehensive reporting of the study results, including both positive and negative outcomes, is required.

  • This reporting aids in evaluating the device’s safety and efficacy.
Regulatory Pathway
  • Depending on the results of the clinical trial, medical device companies may need to navigate the regulatory pathway for device approval or clearance

  • IMOH reviews the clinical data as part of this process
Collaboration with IMOH
  • Maintaining open communication and collaboration with the IMOH is key to ensuring a smooth and compliant clinical trial process.

  • Timely responses to requests for information or data are vital.

Navigating the regulatory landscape for clinical trials in Israel may seem complex, but with the right expertise and consultancy support, it can be a strategic step in advancing your medical device innovation.

Our team, with over 20 years of experience, can guide you through the IMOH requirements, facilitate ethical reviews, and ensure your clinical trials in Israel are conducted following the highest standards of quality, safety, and compliance.

For Medical Device Clinical Studies & Evaluation contact us!

Diverse Patient Populations for Medical Device Studies

Israel’s population is characterized by diversity, both in ethnicity and health conditions, with extensive, reliable Electronic Health Records.

This diversity offers a valuable resource for medical device companies seeking to conduct clinical studies.

Whether a device targets specific demographics or requires a broad spectrum of patients for testing, Israel’s diverse population provides the necessary diversity for comprehensive and representative clinical evaluations.

Business Infrastructure and Support for medical device in Israel

Medical device companies conducting clinical studies in Israel benefit from a robust business infrastructure.

The country offers a supportive ecosystem of legal, financial, and consulting services tailored to the needs of life science companies.

This infrastructure simplifies administrative tasks, project management, and compliance with regulatory requirements, allowing companies to focus on core research and development activities.

Real-World Medical Device Testing Ground

In a competitive global market, speed to market is a critical factor.

Israel’s agile and innovative environment enables medical device companies to fast-track their research and development efforts.

Streamlined regulatory processes, access to cutting-edge technologies, and a collaborative mindset allow companies to accelerate innovation without compromising quality or safety.

Collaborative ventures in Israel provide access to a wealth of knowledge, resources, and potential investors, enhancing the research and evaluation process.

Israel’s healthcare system emphasizes efficiency and preventive care, making it an ideal environment for assessing the real-world performance and impact of medical devices.

Medical device Israeli regulation Vs. FDA & CE

Success in Israel can open doors to global markets.

Medical device companies conducting clinical studies and evaluations in Israel may find it easier to obtain approvals from other regulatory authorities worldwide.

Israel adheres to high standards, aligning with FDA and CE/MDR regulatory requirements and medical device classification.

Israel’s commitment to rigorous standards and its reputation for innovation can enhance a device’s credibility and market acceptance globally.

In a world where medical device innovation reigns supreme, selecting the right location for clinical studies and evaluations is crucial.

Israel’s advantages for medical device clinical trials, clinical evaluation, and performance studies:

  • A unique blend of a thriving innovation ecosystem
  • World-class healthcare institutions
  • Diverse patient populations
  • Regulatory expertise
  • Business support infrastructure
  • Commitment to patient safety

By harnessing Israel’s resources and expertise, medical device companies can expedite the development, evaluation, and market entry of their medical devices while ensuring the highest standards of quality and safety.

For companies striving to push the boundaries of innovation and make a substantial impact on healthcare, Israel stands as the preferred destination for clinical studies, evaluations, and performance testing.

With over 20 years of proven regulatory expertise, and an extensive network including identifying the most suitable hospitals for your medical device clinical evaluations and performance.

For Medical device clinical trials, clinical evaluation, and performance studies regulatory partners contact us

Related Articles
Contact me today
Scroll to Top
Skip to content